Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124970622 | 12497062 | 2 | F | 20160628 | 20160624 | 20160707 | EXP | IT-DEPOMED, INC.-IT-2016DEP010181 | DEPOMED | 65.00 | YR | F | Y | 65.00000 | KG | 20160707 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124970622 | 12497062 | 1 | PS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 250 ?G, UNK | 22569 | 250 | UG | ||||||||
| 124970622 | 12497062 | 2 | SS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 700 ?G, UNK | 22569 | 700 | UG | ||||||||
| 124970622 | 12497062 | 3 | SS | DAPAROX /00830802/ | PAROXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | TABLET | ||||||
| 124970622 | 12497062 | 4 | SS | METHYLENE BLUE. | METHYLENE BLUE | 1 | Intravenous (not otherwise specified) | 100 MG, OVER 20 MINUTES, TWICE | 0 | 100 | MG | SOLUTION FOR INJECTION | |||||||
| 124970622 | 12497062 | 5 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | U | 0 | ||||||||||
| 124970622 | 12497062 | 6 | C | VALSARTAN. | VALSARTAN | 1 | UNK | U | 0 | ||||||||||
| 124970622 | 12497062 | 7 | C | LORMETAZEPAM | LORMETAZEPAM | 1 | UNK | U | 0 | ||||||||||
| 124970622 | 12497062 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | 0 | ||||||||||
| 124970622 | 12497062 | 9 | C | PROPOFOL. | PROPOFOL | 1 | 50 ?G, UNK | 0 | 50 | UG | |||||||||
| 124970622 | 12497062 | 10 | C | PROPOFOL. | PROPOFOL | 1 | 1354 MG, UNK | 0 | 1354 | MG | |||||||||
| 124970622 | 12497062 | 11 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 124970622 | 12497062 | 12 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 124970622 | 12497062 | 13 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | 80 MG, UNK | 0 | 80 | MG | |||||||||
| 124970622 | 12497062 | 14 | C | SEVOFLURANE. | SEVOFLURANE | 1 | 0.5-1 MAC/HR | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124970622 | 12497062 | 1 | General anaesthesia |
| 124970622 | 12497062 | 3 | Depression |
| 124970622 | 12497062 | 4 | Vasoplegia syndrome |
| 124970622 | 12497062 | 5 | Product used for unknown indication |
| 124970622 | 12497062 | 6 | Product used for unknown indication |
| 124970622 | 12497062 | 7 | Product used for unknown indication |
| 124970622 | 12497062 | 8 | Product used for unknown indication |
| 124970622 | 12497062 | 9 | Anaesthesia |
| 124970622 | 12497062 | 11 | Anaesthesia |
| 124970622 | 12497062 | 12 | Anaesthesia |
| 124970622 | 12497062 | 14 | Anaesthesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124970622 | 12497062 | LT |
| 124970622 | 12497062 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124970622 | 12497062 | Coma | |
| 124970622 | 12497062 | Drug interaction | |
| 124970622 | 12497062 | Extrapyramidal disorder | |
| 124970622 | 12497062 | Generalised tonic-clonic seizure | |
| 124970622 | 12497062 | Hyperreflexia | |
| 124970622 | 12497062 | Hyperthermia | |
| 124970622 | 12497062 | Muscle rigidity | |
| 124970622 | 12497062 | Nystagmus | |
| 124970622 | 12497062 | Serotonin syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |